Basilea Pharmaceutica AG
BPMUF
$54.00
$1.172.22%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.51% | 73.49% | |||
| Total Other Revenue | -1.51% | 268.97% | |||
| Total Revenue | -1.51% | 81.23% | |||
| Cost of Revenue | -1.51% | 29.60% | |||
| Gross Profit | -1.51% | 189.87% | |||
| SG&A Expenses | -1.51% | 10.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.51% | 25.36% | |||
| Operating Income | -1.51% | 473.30% | |||
| Income Before Tax | -1.51% | 655.53% | |||
| Income Tax Expenses | 1.50% | 69.44% | |||
| Earnings from Continuing Operations | -1.51% | 186.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.51% | 186.65% | |||
| EBIT | -1.51% | 473.30% | |||
| EBITDA | -1.51% | 453.77% | |||
| EPS Basic | -1.51% | 186.42% | |||
| Normalized Basic EPS | -1.51% | 654.84% | |||
| EPS Diluted | -1.51% | 172.48% | |||
| Normalized Diluted EPS | -1.51% | 652.10% | |||
| Average Basic Shares Outstanding | 0.00% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
